Precipio Reports Q2 2024 Revenue Of $4.4M Vs $4.33M Est; Expects Pathology Division's Revenues Will Reach More Than $1.5M Per Month By Year End
Portfolio Pulse from Benzinga Newsdesk
Precipio, Inc. (NASDAQ: PRPO) reported Q2 2024 revenue of $4.4M, surpassing the estimate of $4.33M. The company expects its Pathology Division's revenues to exceed $1.5M per month by year-end.
July 17, 2024 | 1:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Precipio, Inc. reported Q2 2024 revenue of $4.4M, beating the estimate of $4.33M. The company expects its Pathology Division's revenues to exceed $1.5M per month by year-end, indicating strong growth potential.
The revenue beat and optimistic forecast for the Pathology Division suggest strong growth potential, likely leading to positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100